Exploring contractile protein mechanisms and target medications for cardiomyopathic patients with diastolic dysfunction
Abstract Genetic defects have been increasingly found in cardiomyopathies, which are often present with mutations in cardiac contractile proteins. These congenital defects involve numerous intracellular pathways and share several critical clinical features, such as systolic or diastolic dysfunction...
Saved in:
Main Authors: | Dustin Gerber (Author), Junjun Quan (Author), Bo Pan (Author), Xupei Huang (Author), Jie Tian (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A green tea extract catechin EGCg: Therapeutic potential for pediatric cardiomyopathies
by: Junjun Quan, et al.
Published: (2023) -
Increases in [IP3]i aggravates diastolic [Ca2+] and contractile dysfunction in Chagas' human cardiomyocytes.
by: Alfredo Mijares, et al.
Published: (2020) -
A large thrombus on false tendon in a cardiomyopathic patient
by: Ali Hosseinsabet
Published: (2014) -
Effects of Cholinergic Stimulation with Pyridostigmine Bromide on Chronic Chagasic Cardiomyopathic Mice
by: Marília Beatriz de Cuba, et al.
Published: (2014) -
Mechanism of Statin-Induced Contractile Dysfunction in Rat Cultured Skeletal Myofibers
by: Syoko Tanaka, et al.
Published: (2010)